fenil210/Med-Lamma huggingface dataset:
What is (are) Oral Cavity and Oropharyngeal Cancer ?
Key Points
                    - Oral cavity and oropharyngeal cancer are diseases in which malignant (cancer) cells form in the mouth and throat.    - The number of new cases of oral cavity and oropharyngeal cancer and the number of deaths from oral cavity and oropharyngeal cancer varies by race and gender.    - Different factors increase or decrease the risk of oral cavity and oropharyngeal cancer.
                
                
                    Oral cavity and oropharyngeal cancer are diseases in which malignant (cancer) cells form in the mouth and throat.
                    Oral cavity cancer forms in any of these tissues of the oral cavity:         - The front two thirds of the tongue.    - The gingiva (gums).    - The buccal mucosa (the lining of the inside of the cheeks).    - The floor (bottom) of the mouth under the tongue.    - The hard palate (the front of the roof of the mouth).    - The retromolar trigone (the small area behind the wisdom teeth).          Oropharyngeal cancer forms in any of these tissues of the oropharynx:         - The middle part of the pharynx (throat) behind the mouth.    - The back one third of the tongue.    - The soft palate (the back of the roof of the mouth).    - The side and back walls of the throat.    - The tonsils.          Most oral cavity and oropharyngeal cancers start in squamous cells, the thin, flat cells that line the lips, oral cavity, and oropharynx. Cancer that forms in squamous cells is called squamous cell carcinoma.   See the following PDQ summaries for more information about the screening, diagnosis, and treatment of oral cavity and oropharyngeal cancer:         -  Oral Cavity and Oropharyngeal Cancer Prevention     -  Lip and Oral Cavity Cancer Treatment     -  Oropharyngeal Cancer Treatment
                
                
                    The number of new cases of oral cavity and oropharyngeal cancer and the number of deaths from oral cavity and oropharyngeal cancer varies by race and gender.
                    Over the past ten years, the number of new cases and deaths from oral cavity and oropharyngeal cancer slightly increased in white men and women. The number slightly decreased among black men and women.   Oral cavity and oropharyngeal cancer is more common in men than in women. Although oral cavity and oropharyngeal cancer may occur in adults of any age, it occurs most often in those aged 55 to 64 years.   France, Brazil, and parts of Asia have much higher rates of oral cavity and oropharyngeal cancer than most other countries.    The number of new cases of oropharyngeal cancer caused by certain types of human papillomavirus (HPV) infection has increased. One kind of HPV, called HPV 16, is often passed from one person to another during sexual activity. + CancerGov + Oral Cavity and Oropharyngeal Cancer
Who is at risk for Oral Cavity and Oropharyngeal Cancer? ?
The number of new cases of oral cavity and oropharyngeal cancer and the number of deaths from oral cavity and oropharyngeal cancer varies by race and gender. Over the past ten years, the number of new cases and deaths from oral cavity and oropharyngeal cancer slightly increased in white men and women. The number slightly decreased among black men and women.   Oral cavity and oropharyngeal cancer is more common in men than in women. Although oral cavity and oropharyngeal cancer may occur in adults of any age, it occurs most often in those aged 55 to 64 years.   France, Brazil, and parts of Asia have much higher rates of oral cavity and oropharyngeal cancer than most other countries.    The number of new cases of oropharyngeal cancer caused by certain types of human papillomavirus (HPV) infection has increased. One kind of HPV, called HPV 16, is often passed from one person to another during sexual activity. + CancerGov + Oral Cavity and Oropharyngeal Cancer
Who is at risk for Oral Cavity and Oropharyngeal Cancer? ?
Different factors increase or decrease the risk of oral cavity and oropharyngeal cancer. Anything that increases your chance of getting a disease is called a risk factor. Anything that decreases your chance of getting a disease is called a protective factor.    For information about risk factors and protective factors for oral cavity and oropharyngeal cancer, see the PDQ summary on Oral Cavity and Oropharyngeal Cancer Prevention. + CancerGov + Oral Cavity and Oropharyngeal Cancer
what research (or clinical trials) is being done for Adult Non-Hodgkin Lymphoma ?
New types of treatment are being tested in clinical trials.
				                    This summary section describes treatments that are being studied in clinical trials. It may not mention every new treatment being studied. Information about clinical trials is available from the NCI website.     Vaccine therapy     Vaccine therapy is a type of biologic therapy. Biologic therapy is a treatment that uses the patients immune system to fight cancer. Substances made by the body or made in a laboratory are used to boost, direct, or restore the bodys natural defenses against cancer. This type of cancer treatment is also called biotherapy or immunotherapy. Vaccine therapy can also be a type of targeted therapy.
				                
				                
				                    Patients may want to think about taking part in a clinical trial.
				                    For some patients, taking part in a clinical trial may be the best treatment choice. Clinical trials are part of the cancer research process. Clinical trials are done to find out if new cancer treatments are safe and effective or better than the standard treatment.   Many of today's standard treatments for cancer are based on earlier clinical trials. Patients who take part in a clinical trial may receive the standard treatment or be among the first to receive a new treatment.   Patients who take part in clinical trials also help improve the way cancer will be treated in the future. Even when clinical trials do not lead to effective new treatments, they often answer important questions and help move research forward.
				                
				                
				                    Patients can enter clinical trials before, during, or after starting their cancer treatment.
				                    Some clinical trials only include patients who have not yet received treatment. Other trials test treatments for patients whose cancer has not gotten better. There are also clinical trials that test new ways to stop cancer from recurring (coming back) or reduce the side effects of cancer treatment.   Clinical trials are taking place in many parts of the country. See the Treatment Options section that follows for links to current treatment clinical trials. These have been retrieved from NCI's listing of clinical trials. + CancerGov + Adult Non-Hodgkin Lymphoma
Who is at risk for Adult Non-Hodgkin Lymphoma? ?
Age, gender, and a weakened immune system can affect the risk of adult non-Hodgkin lymphoma. Anything that increases your risk of getting a disease is called a risk factor. Having a risk factor does not mean that you will get cancer; not having risk factors doesnt mean that you will not get cancer. Talk with your doctor if you think you may be at risk.    These and other risk factors may increase the risk of certain types of adult non-Hodgkin lymphoma:         - Being older, male, or white.    - Having one of the following medical conditions:               - An inherited immune disorder (such as hypogammaglobulinemia or Wiskott-Aldrich syndrome).      - An autoimmune disease (such as rheumatoid arthritis, psoriasis, or Sjgren syndrome).      - HIV/AIDS.      - Human T-lymphotrophic virus type I or Epstein-Barr virus infection.      - Helicobacter pylori infection.             - Taking immunosuppressant drugs after an organ transplant. + CancerGov + Adult Non-Hodgkin Lymphoma
What are the symptoms of Adult Non-Hodgkin Lymphoma ?
Signs and symptoms of adult non-Hodgkin lymphoma include swelling in the lymph nodes, fever, night sweats, weight loss, and fatigue. These signs and symptoms may be caused by adult non-Hodgkin lymphoma or by other conditions. Check with your doctor if you have any of the following:         - Swelling in the lymph nodes in the neck, underarm, groin, or stomach.    - Fever for no known reason.    - Recurring night sweats.    - Feeling very tired.    - Weight loss for no known reason.    - Skin rash or itchy skin.    - Pain in the chest, abdomen, or bones for no known reason.        When fever, night sweats, and weight loss occur together, this group of symptoms is called B symptoms.    Other signs and symptoms of adult non-Hodgkin lymphoma may occur and depend on the following:          - Where the cancer forms in the body.    - The size of the tumor.    - How fast the tumor grows. + CancerGov + Adult Non-Hodgkin Lymphoma
What is the outlook for Adult Non-Hodgkin Lymphoma ?
Certain factors affect prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery) and treatment options depend on the following:         - The stage of the cancer.    - The type of non-Hodgkin lymphoma.     - The amount of lactate dehydrogenase (LDH) in the blood.    - Whether there are certain changes in the genes.    - The patients age and general health.    - Whether the lymphoma has just been diagnosed or has recurred (come back).        For non-Hodgkin lymphoma during pregnancy, the treatment options also depend on:         - The wishes of the patient.    - Which trimester of pregnancy the patient is in.    - Whether the baby can be delivered early.        Some types of non-Hodgkin lymphoma spread more quickly than others do. Most non-Hodgkin lymphomas that occur during pregnancy are aggressive. Delaying treatment of aggressive lymphoma until after the baby is born may lessen the mother's chance of survival. Immediate treatment is often recommended, even during pregnancy. + CancerGov + Adult Non-Hodgkin Lymphoma
what research (or clinical trials) is being done for Kaposi Sarcoma ?
New types of treatment are being tested in clinical trials.
                    This summary section describes treatments that are being studied in clinical trials. It may not mention every new treatment being studied. Information about clinical trials is available from the NCI website.     Targeted therapy     Targeted therapy is a type of treatment that uses drugs or other substances to identify and attack specific cancer cells without harming normal cells. Monoclonal antibody therapy and tyrosine kinase inhibitors (TKIs) are types of targeted therapy being studied in the treatment of Kaposi sarcoma.    Monoclonal antibody therapy is a cancer treatment that uses antibodies made in the laboratory from a single type of immune system cell. These antibodies can identify substances on cancer cells or normal substances that may help cancer cells grow. The antibodies attach to the substances and kill the cancer cells, block their growth, or keep them from spreading. Monoclonal antibodies are given by infusion. These may be used alone or to carry drugs, toxins, or radioactive material directly to cancer cells.      Bevacizumab is a monoclonal antibody that is being studied in the treatment of Kaposi sarcoma.    TKIs are targeted therapy drugs that block signals needed for tumors to grow.      Imatinib mesylate is a TKI being studied in the treatment of Kaposi sarcoma.
                              
                
                    Patients may want to think about taking part in a clinical trial.
                    For some patients, taking part in a clinical trial may be the best treatment choice. Clinical trials are part of the cancer research process. Clinical trials are done to find out if new cancer treatments are safe and effective or better than the standard treatment.   Many of today's standard treatments for cancer are based on earlier clinical trials. Patients who take part in a clinical trial may receive the standard treatment or be among the first to receive a new treatment.   Patients who take part in clinical trials also help improve the way cancer will be treated in the future. Even when clinical trials do not lead to effective new treatments, they often answer important questions and help move research forward.
                
                
                    Patients can enter clinical trials before, during, or after starting their cancer treatment.
                    Some clinical trials only include patients who have not yet received treatment. Other trials test treatments for patients whose cancer has not gotten better. There are also clinical trials that test new ways to stop cancer from recurring (coming back) or reduce the side effects of cancer treatment.   Clinical trials are taking place in many parts of the country. See the Treatment Options section that follows for links to current treatment clinical trials. These have been retrieved from NCI's listing of clinical trials. + CancerGov + Kaposi Sarcoma
What is (are) Liver (Hepatocellular) Cancer ?
Key Points
                    - Liver cancer is a disease in which malignant (cancer) cells form in the tissues of the liver.    - Liver cancer is not common in the United States.    - Being infected with certain types of the hepatitis virus can cause hepatitis and increase the risk of liver cancer.         - Hepatitis A     - Hepatitis B     - Hepatitis C     - Hepatitis D     - Hepatitis E     - Hepatitis G
                
                
                    Liver cancer is a disease in which malignant (cancer) cells form in the tissues of the liver.
                    The liver is one of the largest organs in the body. It has four lobes and fills the upper right side of the abdomen inside the rib cage. Three of the many important functions of the liver are:         - To filter harmful substances from the blood so they can be passed from the body in stools and urine.    - To make bile to help digest fats from food.     - To store glycogen (sugar), which the body uses for energy.          See the following PDQ summaries for more information about liver (hepatocellular) cancer:         -  Liver (Hepatocellular) Cancer Screening     -  Adult Primary Liver Cancer Treatment     -  Childhood Liver Cancer Treatment
                
                
                    Liver cancer is not common in the United States.
                    Liver cancer is the fourth most common cancer and the third leading cause of cancer death in the world. In the United States, men, especially Asian/Pacific Islander men, have an increased risk of liver cancer. The number of new cases of liver cancer and the number of deaths from liver cancer continue to increase, especially among middle-aged black, Hispanic, and white men. People are usually older than 40 years when they develop this cancer.    Finding and treating liver cancer early may prevent death from liver cancer. + CancerGov + Liver (Hepatocellular) Cancer
what research (or clinical trials) is being done for Liver (Hepatocellular) Cancer ?
Cancer prevention clinical trials are used to study ways to prevent cancer.
                    Cancer prevention clinical trials are used to study ways to lower the risk of developing certain types of cancer. Some cancer prevention trials are conducted with healthy people who have not had cancer but who have an increased risk for cancer. Other prevention trials are conducted with people who have had cancer and are trying to prevent another cancer of the same type or to lower their chance of developing a new type of cancer. Other trials are done with healthy volunteers who are not known to have any risk factors for cancer.    The purpose of some cancer prevention clinical trials is to find out whether actions people take can prevent cancer. These may include eating fruits and vegetables, exercising, quitting smoking, or taking certain medicines, vitamins, minerals, or food supplements.
                
                
                    New ways to prevent liver cancer are being studied in clinical trials.
                    Clinical trials are taking place in many parts of the country. Information about clinical trials can be found in the Clinical Trials section of the NCI website. Check NCI's list of cancer clinical trials for liver cancer prevention trials that are now accepting patients. + CancerGov + Liver (Hepatocellular) Cancer
What is (are) Chronic Lymphocytic Leukemia ?
Key Points
                    - Chronic lymphocytic leukemia is a type of cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell).    - Leukemia may affect red blood cells, white blood cells, and platelets.    - Older age can affect the risk of developing chronic lymphocytic leukemia.    - Signs and symptoms of chronic lymphocytic leukemia include swollen lymph nodes and tiredness.     - Tests that examine the blood, bone marrow, and lymph nodes are used to detect (find) and diagnose chronic lymphocytic leukemia.    - Certain factors affect treatment options and prognosis (chance of recovery).
                
                
                    Chronic lymphocytic leukemia is a type of cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell).
                    Chronic lymphocytic leukemia (also called CLL) is a blood and bone marrow disease that usually gets worse slowly. CLL is one of the most common types of leukemia in adults. It often occurs during or after middle age; it rarely occurs in children.
                
                
                    Leukemia may affect red blood cells, white blood cells, and platelets.
                    Normally, the body makes blood stem cells (immature cells) that become mature blood cells over time. A blood stem cell may become a myeloid stem cell or a lymphoid stem cell.   A myeloid stem cell becomes one of three types of mature blood cells:         -  Red blood cells that carry oxygen and other substances to all tissues of the body.    -  White blood cells that fight infection and disease.     -  Platelets that form blood clots to stop bleeding.        A lymphoid stem cell becomes a lymphoblast cell and then one of three types of lymphocytes (white blood cells):         -  B lymphocytes that make antibodies to help fight infection.    -  T lymphocytes that help B lymphocytes make antibodies to fight infection.    -  Natural killer cells that attack cancer cells and viruses.         In CLL, too many blood stem cells become abnormal lymphocytes and do not become healthy white blood cells. The abnormal lymphocytes may also be called leukemia cells. The lymphocytes are not able to fight infection very well. Also, as the number of lymphocytes increases in the blood and bone marrow, there is less room for healthy white blood cells, red blood cells, and platelets. This may cause infection, anemia, and easy bleeding.    This summary is about chronic lymphocytic leukemia. See the following PDQ summaries for more information about leukemia:          -  Adult Acute Lymphoblastic Leukemia Treatment.    -  Childhood Acute Lymphoblastic Leukemia Treatment.    -  Adult Acute Myeloid Leukemia Treatment.    -  Childhood Acute Myeloid Leukemia/Other Myeloid Malignancies Treatment.    -  Chronic Myelogenous Leukemia Treatment.    -  Hairy Cell Leukemia Treatment. + CancerGov + Chronic Lymphocytic Leukemia
Who is at risk for Chronic Lymphocytic Leukemia? ?
Older age can affect the risk of developing chronic lymphocytic leukemia. Anything that increases your risk of getting a disease is called a risk factor. Having a risk factor does not mean that you will get cancer; not having risk factors doesnt mean that you will not get cancer. Talk with your doctor if you think you may be at risk. Risk factors for CLL include the following:         - Being middle-aged or older, male, or white.    - A family history of CLL or cancer of the lymph system.    - Having relatives who are Russian Jews or Eastern European Jews. + CancerGov + Chronic Lymphocytic Leukemia
What are the symptoms of Chronic Lymphocytic Leukemia ?
Signs and symptoms of chronic lymphocytic leukemia include swollen lymph nodes and tiredness. Usually CLL does not cause any signs or symptoms and is found during a routine blood test. Signs and symptoms may be caused by CLL or by other conditions. Check with your doctor if you have any of the following:         - Painless swelling of the lymph nodes in the neck, underarm, stomach, or groin.    - Feeling very tired.    - Pain or fullness below the ribs.    -  Fever and infection.    - Weight loss for no known reason. + CancerGov + Chronic Lymphocytic Leukemia
How to diagnose Chronic Lymphocytic Leukemia ?
Tests that examine the blood, bone marrow, and lymph nodes are used to detect (find) and diagnose chronic lymphocytic leukemia. The following tests and procedures may be used:         -   Physical exam and history : An exam of the body to check general signs of health, including checking for signs of disease, such as lumps or anything else that seems unusual. A history of the patients health habits and past illnesses and treatments will also be taken.     -   Complete blood count (CBC) with differential : A procedure in which a sample of blood is drawn and checked for the following:                -  The number of red blood cells and platelets.      - The number and type of white blood cells.      - The amount of hemoglobin (the protein that carries oxygen) in the red blood cells.      - The portion of the blood sample made up of red blood cells.              -   Immunophenotyping : A laboratory test in which the antigens or markers on the surface of a blood or bone marrow cell are checked to see if they are lymphocytes or myeloid cells. If the cells are malignant lymphocytes (cancer), they are checked to see if they are B lymphocytes or T lymphocytes.    -   FISH (fluorescence in situ hybridization): A laboratory technique used to look at genes or chromosomes in cells and tissues. Pieces of DNA that contain a fluorescent dye are made in the laboratory and added to cells or tissues on a glass slide. When these pieces of DNA bind to specific genes or areas of chromosomes on the slide, they light up when viewed under a microscope with a special light.     -   Flow cytometry : A laboratory test that measures the number of cells in a sample, the percentage of live cells in a sample, and certain characteristics of cells, such as size, shape, and the presence of tumor markers on the cell surface. The cells are stained with a light-sensitive dye, placed in a fluid, and passed in a stream before a laser or other type of light. The measurements are based on how the light-sensitive dye reacts to the light.    -   IgVH gene mutation test: A laboratory test done on a bone marrow or blood sample to check for an IgVH gene mutation. Patients with an IgVH gene mutation have a better prognosis.    -   Bone marrow aspiration and biopsy : The removal of bone marrow, blood, and a small piece of bone by inserting a hollow needle into the hipbone or breastbone. A pathologist views the bone marrow, blood, and bone under a microscope to look for abnormal cells. + CancerGov + Chronic Lymphocytic Leukemia
What is the outlook for Chronic Lymphocytic Leukemia ?
Certain factors affect treatment options and prognosis (chance of recovery). Treatment options depend on:         - The stage of the disease.    - Red blood cell, white blood cell, and platelet blood counts.    - Whether there are signs or symptoms, such as fever, chills, or weight loss.    - Whether the liver, spleen, or lymph nodes are larger than normal.    - The response to initial treatment.    - Whether the CLL has recurred (come back).        The prognosis (chance of recovery) depends on:         - Whether there is a change in the DNA and the type of change, if there is one.    - Whether lymphocytes are spread throughout the bone marrow.    - The stage of the disease.    - Whether the CLL gets better with treatment or has recurred (come back).    - Whether the CLL progresses to lymphoma or prolymphocytic leukemia.    - The patient's general health. + CancerGov + Chronic Lymphocytic Leukemia